Unknown

Dataset Information

0

Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19.


ABSTRACT: Coronavirus disease 2019 (COVID-19), reminiscent of the severe acute respiratory syndrome (SARS) outbreak in 2003, has been a tragic disaster to people all over the world. As there is no specific drug for COVID-19, neutralizing antibodies are attracting more and more attention as one of the most effective means to combat the pandemic. Here, we introduced the etiological and serological characteristics of COVID-19, discussed the current stage of development of human monoclonal antibodies against SARS-CoV-2 and summarized the antigenic epitopes in the S glycoprotein, which may deepen the understanding of the profile of immune recognition and response against SARS-CoV-2 and provide insight for the design of effective vaccines and antibody-based therapies.

SUBMITTER: Chen J 

PROVIDER: S-EPMC7779898 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7901298 | biostudies-literature
| S-EPMC7912592 | biostudies-literature
| S-EPMC7192075 | biostudies-literature
| S-EPMC5625485 | biostudies-literature
| S-EPMC8375150 | biostudies-literature
| S-EPMC8915435 | biostudies-literature
| S-EPMC8152891 | biostudies-literature
2023-10-09 | PXD043818 | Pride
| S-EPMC8054133 | biostudies-literature
| S-EPMC8623253 | biostudies-literature